Authored by: The Cannabis Industry Council Germany’s legal cannabis industry continues to set the pace for Europe, and in April 2026, the global sector will once again converge in the capital for the International Cannabis Business Conference (ICBC) Berlin 2026. Taking place from 13th-15th of April at the iconic Estrel Berlin Hotel, ICBC remains Europe’s […]
Read More
The Cannabis Industry Council welcomes the publication of new guidance for police officers and staff on prescribed medicinal cannabis, developed by the Association of Police Controlled Drug Liaison Officers (APCDLO) and endorsed across policing bodies For patients, clarity around the law is not a “nice to have”, it is essential. Too many people who are […]
Read More
In December 2025, President Trump signed an Executive Order directing U.S. federal agencies to move forward with the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act. While this does not immediately change the legal status of cannabis at a federal level, it represents a significant moment in the ongoing […]
Read More
Every few months, medical cannabis becomes a headline again in mainstream media outlets. The language is familiar, the framing is predictable and the reactions of anger, defensiveness and division follows just as reliably. Whilst we are directly challenging the false assertions head on with the publication that recently published an article on medical cannabis prescriptions […]
Read More
The Cannabis Industry Council has submitted a detailed response to the Advisory Council on the Misuse of Drugs’ call for evidence on cannabis-based products for medicinal use (CBPMs). Our submission reflects the expertise and experiences of our diverse membership across the UK medical cannabis sector. Our Position The CIC’s submission addresses the fundamental disconnect between […]
Read More
The Advisory Council on the Misuse of Drugs (ACMD) is conducting a comprehensive review of the 2018 changes to cannabis medicines regulations in the UK. This review will directly shape how CBPMs are regulated, prescribed, and accessed for years to come. The consultation runs until 17 October 2025, 11:59 PM. This briefing provides guidance to […]
Read More
Hannah Deacon was a wonderful mother, partner, and friend to many of us. Her passing on 6 May 2025 is absolutely devastating news, which we are trying to digest and comprehend. Hannah died at just 45 years old, following what was described as a ‘short and brutal illness’. Hannah was an absolute force of nature, […]
Read More
Authored by: The International Cannabis Business Conference This year will be the biggest ever for Germany’s emerging legal cannabis industry, and the International Cannabis Business Conference (ICBC) will be at the heart of it all. ICBC is once again bringing its flagship conference, Europe’s largest and longest-running cannabis B2B event, to Berlin on April 29th-30th, […]
Read More
CIC Co-Chairs Dr Callie Seaman and Jamie Bartley offer their thoughts on the past year As 2024 draws to a close, we are delighted to reflect on a year of significant progress and collaboration within the cannabis industry. Our collective efforts have not only advanced our industry but have also positioned us at the forefront […]
Read More
Michael Roberts (MR) is reportedly the first NHS patient to be reimbursed for cannabis flower medicine to manage chemotherapy-induced nausea and vomiting (CINV). A case study about MR’s condition and subsequent reimbursement has been written by Roberts M, Brown M D, Moreno-Sanz G, and published by Cureus (part of Springer Nature). The following are extracts […]
Read More